Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges

Molecular tinkering of G protein‐coupled receptors: an evolutionary success

Bockaert, J., & Pin, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1723 · Cited by 1,548 · see citing works

A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,256 · see citing works

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B. K., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,119 · see citing works

Handbook of Experimental Pharmacology, vol 14.

Freedman, A. D. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.1972.03650020118031 · Cited by 777 · see citing works

Oligomerization of G-protein-coupled transmitter receptors

Bouvier, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067575 · Cited by 668 · see citing works

Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function

Kristiansen, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.05.002 · Cited by 611 · see citing works

G Protein-coupled Receptors

Gether, U., & Kobilka, B. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.17979 · Cited by 585 · see citing works

β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors

Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T. A., Bouvier, M., & Piñeyro, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1936664100 · Cited by 522 · see citing works

G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology

Milligan, G. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000497 · Cited by 474 · see citing works

Vasopressin Receptors

Birnbaumer, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00304-0 · Cited by 343 · see citing works

Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis

Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan‐Cadars, M., Jockers, R., Barberis, C., & Bouvier, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0222 · Cited by 323 · see citing works

Ligand-selective receptor conformations revisited: the promise and the problem

Kenakin, T. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00167-6 · Cited by 322 · see citing works

The oxytocin receptor

Zingg, H. H., & Laporte, S. A. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00080-8 · Cited by 316 · see citing works

Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series

Daniels, D. J., Lenard, N. R., Etienne, C. L., Law, P., Roerig, S. C., & Portoghese, P. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506627102 · Cited by 297 · see citing works

The Binding Site of Neuropeptide Vasopressin V1a Receptor

Mouillac, B., Chini, B., Balestre, M.-N., Elands, J., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Jard, S., & Barberis, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25771 · Cited by 262 · see citing works

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

Chini, B., Mouillac, B., Ala, Y., Balestre, M. N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., & Jard, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07211.x · Cited by 179 · see citing works

G protein coupled receptor dimerization: implications in modulating receptor function

Gomes, I., Jordan, B. A., Gupta, A., Rios, C., Trapaidze, N., & Devi, L. A. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100219 · Cited by 173 · see citing works

Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with β-arrestin and their trafficking patterns

Terrillon, S., Barberis, C., & Bouvier, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305322101 · Cited by 158 · see citing works

Structure, function, and phylogeny of [Arg8]vasotocinreceptors from teleost fish and toad.

Mahlmann, S., Meyerhof, W., Hausmann, H., Heierhorst, J., Schönrock, C., Zwiers, H., Lederis, K. P., & Richter, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1342 · Cited by 151 · see citing works

Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains

Rimoldi, V., Reversi, A., Taverna, E., Rosa, P., Francolini, M., Cassoni, P., Parenti, M. D., & Chini, B. (2003) · Oncogene · doi:10.1038/sj.onc.1206612 · Cited by 145 · see citing works

Amino acids and peptides. LXXI. Synthesis of 1-deamino-8-D-γ-aminobutyrine-vasopressin, 1-deamino-8-D-lysine-vasopressin, and 1-deamino-8-D-arginine-vasopressin

Zaoral, M., Kolc, J., & Šorm, F. (1967) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc19671250 · Cited by 142 · see citing works

The oxytocin receptor antagonist atosiban inhibits cell growth via a “biased agonist” mechanism

Reversi, A., Rimoldi, V., Marrocco, T., Cassoni, P., Bussolati, G., Parenti, M., & Chini, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409945200 · Cited by 139 · see citing works

The Human V3 Pituitary Vasopressin Receptor: Ligand Binding Profile and Density-Dependent Signaling Pathways

Thibonnier, M., Preston, J. A., Dulin, N. O., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1997) · Endocrinology · doi:10.1210/endo.138.10.5432 · Cited by 135 · see citing works

Separate Agonist and Peptide Antagonist Binding Sites of the Oxytocin Receptor Defined by Their Transfer into the V2 Vasopressin Receptor

Postina, R., Kojro, E., & Fahrenholz, F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31593 · Cited by 134 · see citing works

'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors

Luttrell, L. M. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300117 · Cited by 128 · see citing works

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin

Chini, B., Mouillac, B., Balestre, M.-N., Trumpp-Kallmeyer, S., Hoflack, J., Hibert, M., Andriolo, M., Pupier, S., Jard, S., & Barberis, C. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01135-0 · Cited by 117 · see citing works

Neurohypophysial peptide systems: processing machinery, hydroosmotic regulation, adaptation and evolution

Acher, R. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90174-7 · Cited by 109 · see citing works

Probing the Existence of G Protein-Coupled Receptor Dimers by Positive and Negative Ligand-Dependent Cooperative Binding

Albizu, L., Balestre, M., Breton, C., Pin, J., Manning, M., Mouillac, B., Barberis, C., & Durroux, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025684 · Cited by 108 · see citing works

Hormones and Calcium: Mechanisms Controlling Uterine Smooth Muscle Contractile Activity

Sanborn, B. M. (2001) · Experimental Physiology · doi:10.1113/eph8602179 · Cited by 99 · see citing works

Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response

Guzzi, F., Zanchetta, D., Cassoni, P., Guzzi, V., Francolini, M., Parenti, M. D., & Chini, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205219 · Cited by 99 · see citing works

Synthesis and some pharmacological properties of [4-threonine,7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid),4-threonine,7-glycine]oxytocin (hydroxy[thr4, gly7]oxytocin), and [7-glycine]oxytocin, peptides with high oxytocic-antidiuretic selectivity

Lowbridge, J., Manning, M., Haldar, J., & Sawyer, W. H. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00211a025 · Cited by 98 · see citing works

G protein‐coupled receptors: a count of 1001 conformations

Vauquelin, G., & Liefde, I. V. (2005) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00319.x · Cited by 91 · see citing works

Design, Synthesis and Some uses of Receptor-Specific Agonists and Antagonists of Vasopressin and Oxytocin

Manning, M., & Sawyer, W. H. (1993) · Journal of Receptor Research · doi:10.3109/10799899309073655 · Cited by 90 · see citing works

1-desamino-8-d-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor

Saito, M., Tahara, A., & Sugimoto, T. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00070-1 · Cited by 82 · see citing works

Oxytocin Receptor Signaling in Myoepithelial and Cancer Cells

Reversi, A., Cassoni, P., & Chini, B. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-9583-7 · Cited by 81 · see citing works

[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors

Derick, S., Cheng, L. L., Voirol, M. J., Stoev, S., Giacomini, M., Wo, N. C., Szeto, H. H., Ben Mimoun, M., Andres, M., Gaillard, R. C., et al. (2002) · Endocrinology · doi:10.1210/en.2002-220363 · Cited by 76 · see citing works

Molecular pharmacology of AVP and OT receptors and therapeutic potential

Barberis, C., Morin, D., Durroux, T., Mouillac, B., Guillon, G., Seyer, R., Hibert, M., Tribollet, E., & Manning, M. (1999) · Drug News & Perspectives · doi:10.1358/dnp.1999.12.5.863621 · Cited by 71 · see citing works

Conformational and Structural Considerations in Oxytocin-Receptor Binding and Biological Activity

Hruby, V. J., Chow, M., & Smith, D. D. (1990) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.002441 · Cited by 70 · see citing works

Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells

Tahara, A., Saito, M., Sugimoto, T., Tomura, Y., Wada, K., Kusayama, T., Tsukada, J., Ishii, N., Yatsu, T., Uchida, W., et al. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702220 · Cited by 64 · see citing works

Mapping the Binding Site of Six Nonpeptide Antagonists to the Human V2-Renal Vasopressin Receptor

Macion-Dazard, R., Callahan, N., Xu, Z., Wu, N., Thibonnier, M., & Shoham, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095554 · Cited by 55 · see citing works

Charged Extracellular Residues, Conserved throughout a G-protein-coupled Receptor Family, Are Required for Ligand Binding, Receptor Activation, and Cell-surface Expression

Hawtin, S. R., Simms, J., Conner, M. T., Lawson, Z., Parslow, R. A., Trim, J. E., Sheppard, A., & Wheatley, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607639200 · Cited by 45 · see citing works

Homo‐ and Hetero‐Dimeric Complex Formations of the Human Oxytocin Receptor

Devost, D., & Zingg, H. H. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.0953-8194.2004.01188.x · Cited by 43 · see citing works

Mapping the Binding Site of Arginine Vasopressin to V 1a and V 1b Vasopressin Receptors

Rodrigo, J., Peña, A., Murat, B., Trueba, M., Durroux, T., Guillon, G., & Rognan, D. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0202 · Cited by 43 · see citing works

From Plants to Man: The GPCR “Tree of Life”

Perez, D. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011890 · Cited by 43 · see citing works

Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer

Devost, D., & Zingg, H. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310461 · Cited by 41 · see citing works

Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays

Chan, W. Y., Wo, N. C., Stoev, S., Cheng, L. L., & Manning, M. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00003.x · Cited by 41 · see citing works

Molecular basis of ligand binding and receptor activation in the oxytocin and vasopressin receptor family

Chini, B., & Fanelli, F. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00008.x · Cited by 36 · see citing works

Bivalent Ligands for G Protein-Coupled Receptors

Messer, W. S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384213 · Cited by 36 · see citing works

Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue

Chini, B., Chinol, M., Cassoni, P., Papi, S., Reversi, A., Areces, L. B., Marrocco, T., Paganelli, G., Manning, M., & Bussolati, G. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601189 · Cited by 36 · see citing works

A molecular model of agonist and nonpeptide antagonist binding to the human V1 vascular vasopressin receptor

Thibonnier, M., Coles, P., Conarty, D. M., Plesnicher, C. L., & Shoham, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39056-1 · Cited by 35 · see citing works

Chimeric strategies for the rational design of bioactive analogs of small peptide hormones

Howl, J., Langel, Ü., Hawtin, S. R., Valkna, A., YARWOOD, N. J., Saar, K., & Wheatley, M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.7.9212082 · Cited by 32 · see citing works

Design of Potent and Selective Agonists for the Human Vasopressin V1bReceptor Based on Modifications of [Deamino-Cys]arginine Vasopressin at Position 4

Cheng, L., Stoev, S. B., Manning, M., Derick, S., Peña, A., Mimoun, M. B., & Guillon, G. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030611c · Cited by 32 · see citing works

Kappa Receptor Bivalent Ligands

Peng, X., & Neumeyer, J. L. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779941251 · Cited by 29 · see citing works

Design and Synthesis of the First Selective Agonists for the Rat Vasopressin V 1b Receptor: Based on Modifications of Deamino-[Cys]arginine Vasopressin at Positions 4 and 8

Peña, A., Murat, B., Trueba, M., Ventura, M. A., Wo, N. C., Szeto, H. H., Cheng, L., Stoev, S. B., Guillon, G., & Manning, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060928n · Cited by 27 · see citing works

Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.

Chini, B., Mouillac, B., Ala, Y., Balestre, M., de la Cotte, N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., & Manning, M. (1995) · PubMed · Cited by 18 · see citing works

A new class of potent bradykinin antagonist dimers

Gera, L., Stewart, J. M., Whalley, E. T., Burkard, M., & Zuzack, J. S. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00099-9 · Cited by 17 · see citing works

The oxytocin receptor: from intracellular signaling to behavior

Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999 · see citing works

Oxytocin in general anxiety and social fear: a translational approach

Neumann, I. D., & Slattery, D. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.004 · Cited by 468 · see citing works

Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics

Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423 · see citing works

Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems

Koshimizu, T., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 413 · see citing works

Dopamine and Oxytocin Interactions Underlying Behaviors: Potential Contributions to Behavioral Disorders

Baskerville, T. A., & Douglas, A. J. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00154.x · Cited by 377 · see citing works

Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆

MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296 · see citing works

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

Dumont, G. J. H., Sweep, F. C. G. J., van der Steen, R., Hermsen, R., Donders, A. R. T., Touw, D. J., van Gerven, J. M. A., Buitelaar, J. K., & Verkes, R. J. (2009) · Social Neuroscience · doi:10.1080/17470910802649470 · Cited by 238 · see citing works

Oxytocin-Induced Analgesia and Scratching Are Mediated by the Vasopressin-1A Receptor in the Mouse

Schorscher-Petcu, A., Sotocinal, S., Ciura, S., Dupre, A., Ritchie, J., Sorge, R. E., Crawley, J. N., Hu, S.-B., Nishimori, K., Young, L. J., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1594-10.2010 · Cited by 189 · see citing works

From ultrasocial to antisocial: A role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

McGregor, I. S., Callaghan, P. D., & Hunt, G. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.132 · Cited by 171 · see citing works

Molecular Basis of Oxytocin Receptor Signalling in the Brain: What We Know and What We Need to Know

Busnelli, M., & Chini, B. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_6 · Cited by 161 · see citing works

Sex-specific modulation of juvenile social play behavior by vasopressin and oxytocin depends on social context

Bredewold, R., Smith, C. J. W., Dumais, K. M., & Veenema, A. H. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00216 · Cited by 157 · see citing works

Interplay between Oxytocin and Sensory Systems in the Orchestration of Socio-Emotional Behaviors

Grinevich, V., & Stoop, R. (2018) · Neuron · doi:10.1016/j.neuron.2018.07.016 · Cited by 139 · see citing works

Neural control of parental behaviors

Kohl, J., & Dulac, C. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.02.002 · Cited by 136 · see citing works

Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans

Martins, D., Mazibuko, N., Zelaya, F. O., Vasilakopoulou, S., Loveridge, J., Oates, A. E., Maltezos, S., Mehta, M. A., Wastling, S. J., Howard, M. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14845-5 · Cited by 130 · see citing works

Oxytocin action in the ventral tegmental area affects sucrose intake

Mullis, K., Kay, K., & Williams, D. L. (2013) · Brain Research · doi:10.1016/j.brainres.2013.03.026 · Cited by 122 · see citing works

Oxytocin receptor is not required for social attachment in prairie voles

Berendzen, K. M., Sharma, R., Alvarado, M., Wei, Y., Rogers, F. D., Simmons, T. C., Seelke, A. M. H., Bond, J. M., Larios, R., Goodwin, N. L., et al. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.011 · Cited by 120 · see citing works

The vasopressin Avpr1b receptor: Molecular and pharmacological studies

Roper, J. A., O'Carroll, A.-M., Young, W. S., & Lolait, S. (2010) · Stress · doi:10.3109/10253890.2010.512376 · Cited by 116 · see citing works

Physiology of invertebrate oxytocin and vasopressin neuropeptides

Gruber, C. W. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2013.072561 · Cited by 110 · see citing works

Detection, processing and reinforcement of social cues: regulation by the oxytocin system

Menon, R., & Neumann, I. D. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00759-w · Cited by 100 · see citing works

Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors

Busnelli, M., Bulgheroni, E., Manning, M., Kleinau, G., & Chini, B. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.202994 · Cited by 102 · see citing works

Ligand-Based Peptide Design and Combinatorial Peptide Libraries to Target G Protein-Coupled Receptors

Gruber, C. W., Muttenthaler, M., & Freissmuth, M. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292474 · Cited by 107 · see citing works

Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats

Juif, P.-E., & Poisbeau, P. (2013) · Pain · doi:10.1016/j.pain.2013.05.003 · Cited by 101 · see citing works

Mice Heterozygous for the Oxytocin Receptor Gene (Oxtr+/−) Show Impaired Social Behaviour but not Increased Aggression or Cognitive Inflexibility: Evidence of a Selective Haploinsufficiency Gene Effect

Sala, M., Braida, D., Donzelli, A., Martucci, R., Busnelli, M., Bulgheroni, E., Rubino, T., Parolaro, D., Nishimori, K., & Chini, B. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02385.x · Cited by 99 · see citing works

Prosocial effects of oxytocin in two mouse models of autism spectrum disorders

Teng, B. L., Nonneman, R. J., Agster, K. L., Nikolova, V. D., Davis, T. T., Riddick, N. V., Baker, L. K., Pedersen, C. A., Jarstfer, M. B., & Moy, S. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.038 · Cited by 98 · see citing works

Increased anxiety and decreased sociability induced by paternal deprivation involve the PVN-PrL OTergic pathway

He, Z., Young, L., Ma, X.-M., Guo, Q., Wang, L., Yang, Y., Luo, L., Yuan, W., Li, L., Zhang, J., et al. (2019) · eLife · doi:10.7554/elife.44026 · Cited by 81 · see citing works

Oxytocin stimulates migration and invasion in human endothelial cells

Cattaneo, M. G., Chini, B., & Vicentini, L. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707609 · Cited by 80 · see citing works

Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species

Muttenthaler, M., Andersson, Å., Vetter, I., Menon, R., Busnelli, M., Ragnarsson, L. K. N., Bergmayr, C., Arrowsmith, S., Deuis, J. R., Chiu, H. S., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aan3398 · Cited by 79 · see citing works

The analgesic effects of oxytocin in the peripheral and central nervous system

Xin, Q., Bai, B., & Liu, W. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2016.12.021 · Cited by 81 · see citing works

The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats

Hicks, C., Jorgensen, W., Brown, C., Fardell, J., Koehbach, J., Gruber, C. W., Kassiou, M., Hunt, G. E., & McGregor, I. S. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02311.x · Cited by 73 · see citing works

Oxytocin and vasopressin: signalling, behavioural modulation and potential therapeutic effects

Rae, M., Lemos Duarte, M., Gomes, I., Camarini, R., & Devi, L. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15481 · Cited by 72 · see citing works

Oxytocin inhibits the activity of acid‐sensing ion channels through the vasopressin, V_1A receptor in primary sensory neurons

Qiu, F., Qiu, C., Cai, H., Liu, T., Qu, Z., Yang, Z., Li, J., Zhou, Q., & Hu, W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12635 · Cited by 67 · see citing works

Gender moderates the effect of oxytocin on social judgments

Hoge, E. A., Anderson, E., Lawson, E. A., Bui, E., Fischer, L. E., Khadge, S. D., Barrett, L. F., & Simon, N. M. (2014) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2402 · Cited by 64 · see citing works

Oxytocin and vasopressin modulate the social response to threat: a preclinical study

Bowen, M. T., & McGregor, I. S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000388 · Cited by 63 · see citing works

Insights into the molecular evolution of oxytocin receptor ligand binding

Koehbach, J., Stockner, T., Bergmayr, C., Muttenthaler, M., & Gruber, C. W. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120256 · Cited by 61 · see citing works

Physiology and pathophysiology of the vasopressinergic system

Vincent, J., & Su, F. (2008) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2008.03.004 · Cited by 59 · see citing works

The impact of early life stress on the central oxytocin system and susceptibility for drug addiction: Applicability of oxytocin as a pharmacotherapy

Baracz, S. J., Everett, N. A., & Cornish, J. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.014 · Cited by 52 · see citing works

Exploring bioactive peptides from natural sources for oxytocin and vasopressin drug discovery

Gruber, C. W., Koehbach, J., & Muttenthaler, M. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.108 · Cited by 49 · see citing works

Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons

Yao, Y., Fu, L., Zhang, X., & van den Pol, A. N. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00452.2011 · Cited by 48 · see citing works

The neurocircuitry involved in oxytocin modulation of methamphetamine addiction

Baracz, S. J., & Cornish, J. L. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.08.001 · Cited by 46 · see citing works

Oxytocin Promotes Accurate Fear Discrimination and Adaptive Defensive Behaviors

Olivera-Pasilio, V., & Dabrowska, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.583878 · Cited by 46 · see citing works

Oxytocin and Related Peptide Hormones: Candidate Anti-Inflammatory Therapy in Early Stages of Sepsis

Mehdi, S. F., Pusapati, S., Khenhrani, R. R., Farooqi, M. S., Sarwar, S., Alnasarat, A., Mathur, N., Metz, C. N., LeRoith, D., Tracey, K. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864007 · Cited by 44 · see citing works

Biopossibility: A Queer Feminist Materialist Science Studies Manifesto, with Special Reference to the Question of Monogamous Behavior

Willey, A. (2016) · Signs · doi:10.1086/684238 · Cited by 44 · see citing works

Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide

Giglio, M. G. D., Muttenthaler, M., Harpsøe, K., Liutkevičiūtė, Z., Keov, P., Eder, T., Rattei, T., Arrowsmith, S., Wray, S., Marek, A., et al. (2017) · Scientific Reports · doi:10.1038/srep41002 · Cited by 44 · see citing works

Oxytocin Increases Neurite Length and Expression of Cytoskeletal Proteins Associated with Neuronal Growth

Lestanova, Z., Bačová, Z., Kiss, A., Havránek, T., Štrbák, V., & Bakoš, J. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0664-9 · Cited by 43 · see citing works

Homo and Heterodimer Ligands: the Twin Drug Approach

Contreras, J., & Sippl, W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374194-3.00018-4 · Cited by 42 · see citing works

Oxytocin Receptor Signaling in Vascular Function and Stroke

McKay, E. C., & Counts, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.574499 · Cited by 41 · see citing works

Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists

Stadler, B., Whittaker, M. R., Exintaris, B., & Middendorff, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.565731 · Cited by 41 · see citing works

Attenuation of Oxytocin and Serotonin 2A Receptor Signaling through Novel Heteroreceptor Formation

Chruścicka, B., Fitzsimons, S. E. W., Borroto‐Escuela, D. O., Druelle, C. M., Stamou, P., Nally, K., Dinan, T. G., Cryan, J. F., Fuxé, K., & Schellekens, H. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00665 · Cited by 34 · see citing works

The Physiology of Proinsulin C-Peptide: Unanswered Questions and a Proposed Model

Yosten, G. L. C., & Kolar, G. R. (2015) · Physiology · doi:10.1152/physiol.00008.2015 · Cited by 33 · see citing works

Possible Involvement of the Rat Hypothalamo‐Neurohypophysial/‐Spinal Oxytocinergic Pathways in Acute Nociceptive Responses

Matsuura, T., Kawasaki, M., Hashimoto, H., Yoshimura, M., Motojima, Y., Saito, R., Ueno, H., Maruyama, T., Ishikura, T., Sabanai, K., et al. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12396 · Cited by 32 · see citing works

The role of peripheral vasopressin 1A and oxytocin receptors on the subcutaneous vasopressin antinociceptive effects

Manzano‐García, A., González‐Hernández, A., Tello-García, I. A., Martı́nez-Lorenzana, G., & Condés‐Lara, M. (2017) · European Journal of Pain · doi:10.1002/ejp.1134 · Cited by 32 · see citing works

Environmental factors may contribute to autism development and male bias: Effects of fragrances on developing neurons

Sealey, L., Hughes, B. W., Pestaner, J. P., Steinemann, A. C., Pace, D. G., & Bagasra, O. (2015) · Environmental Research · doi:10.1016/j.envres.2015.08.025 · Cited by 25 · see citing works

Vasopressin V1a receptors mediate the hypertensive effects of [Pyr1]apelin‐13 in the rat rostral ventrolateral medulla

Griffiths, P. R., Lolait, S. J., Harris, L. E., Paton, J. F. R., & O’Carroll, A. (2017) · The Journal of Physiology · doi:10.1113/jp274178 · Cited by 25 · see citing works

Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors

Loyens, E., Vermoesen, K., Schallier, A., Michotte, Y., & Smolders, I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.11.059 · Cited by 25 · see citing works

Who Plays the Strings in Newborn Analgesia at Birth, Vasopressin or Oxytocin?

Wellmann, S. M., & Bührer, C. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00078 · Cited by 24 · see citing works

Yohimbine as a Starting Point to Access Diverse Natural Product-Like Agents with Re-programmed Activities against Cancer-Relevant GPCR Targets

Paciaroni, N. G., Norwood, V. M., Ratnayake, R., Luesch, H., & Huigens, R. W. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115546 · Cited by 24 · see citing works

Methylation in Syn and Psd95 genes underlie the inhibitory effect of oxytocin on oxycodone-induced conditioned place preference

Fan, X., Shi, G., & Zhao, P. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.10.010 · Cited by 23 · see citing works

Pathophysiological function of oxytocin secreted by neuropeptides: A mini review

Hashimoto, H., Uezono, Y., & Ueta, Y. (2012) · Pathophysiology · doi:10.1016/j.pathophys.2012.07.005 · Cited by 23 · see citing works

Oxytocin increases eye gaze in schizophrenia

Bradley, E. R., Seitz, A., Niles, A. N., Rankin, K. P., Mathalon, D. H., O'Donovan, A., & Woolley, J. D. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.039 · Cited by 22 · see citing works

Vasopressin Proves Essential: Vasopressin and the Modulation of Sensory Processing in Mammals

Bester‐Meredith, J. K., Fancher, A. P., & Mammarella, G. E. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00005 · Cited by 23 · see citing works

Feeding response following central administration of mesotocin and arginine-vasotocin receptor agonists in chicks (Gallus gallus)

Masunari, K., Cline, M. A., Khan, S., & Tachibana, T. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.11.001 · Cited by 21 · see citing works

Role of Oxytocin/Oxytocin Receptor System in Regulation of Cell Growth and Neoplastic Processes

Strunecká, A., Hynie, S., & Klenerová, V. (2009) · Folia Biologica · doi:10.14712/fb2009055050159 · Cited by 21 · see citing works

Effects of Intranasal Oxytocin on Steroid Hormones in Men and Women

Wirth, M. M., Gaffey, A. E., & Martinez, B. S. (2015) · Neuropsychobiology · doi:10.1159/000381023 · Cited by 21 · see citing works

Oxytocin produces thermal analgesia via vasopressin-1a receptor by modulating TRPV1 and potassium conductance in the dorsal root ganglion neurons

Han, R. T., Kim, H.-B., Kim, Y., Choi, K.-M., Park, G. Y., Lee, P. R., Lee, J., Kim, H. Y., Park, C., Kang, Y., et al. (2018) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2018.22.2.173 · Cited by 19 · see citing works

Nature-inspired dimerization as a strategy to modulate neuropeptide pharmacology exemplified with vasopressin and oxytocin

Dekan, Z., Kremsmayr, T., Keov, P., Godin, M., Teakle, N., Duerrauer, L., Xiang, H., Gharib, D., Bergmayr, C., Hellinger, R., et al. (2021) · Chemical Science · doi:10.1039/d0sc05501h · Cited by 19 · see citing works

Oxytocin Receptor Activation Rescues Opioid-Induced Respiratory Depression by Systemic Fentanyl in the Rat

Brackley, A. D., & Toney, G. M. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000535 · Cited by 14 · see citing works

Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias

Janovick, J. A., Spicer, T., Bannister, T. D., Scampavia, L. D., & Conn, P. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181830 · Cited by 16 · see citing works

Is Oxytocin a Player in Antidiuresis?

Sasaki, S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121319 · Cited by 16 · see citing works

Nanomolar Oxytocin Synergizes with Weak Electrical Afferent Stimulation to Activate the Locomotor CPG of the Rat Spinal Cord In Vitro

Dose, F., Zanon, P., Coslovich, T., & Taccola, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092967 · Cited by 15 · see citing works

Involvement of oxytocin in the nucleus tractus solitarii on central cardiovascular control: interactions with glutamate.

Vela, C. N. C., Dı́az-Cabiale, Z., Parrado, C., Narváez, M., Coveñas, R., & Narváez, J. Á. (2010) · PubMed · Cited by 15 · see citing works

Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor

Pierce, M. L., French, J. A., & Murray, T. F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110060 · Cited by 14 · see citing works

Oxytocin Analogues for the Oral Treatment of Abdominal Pain

Kremsmayr, T., Schober, G., Kaltenböck, M., Hoare, B. L., Brierley, S. M., & Muttenthaler, M. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202415333 · Cited by 13 · see citing works

Co-Stimulation of Oxytocin and Arginine-Vasopressin Receptors Affect Hypothalamic Neurospheroid Size

Salehi, M. S., Neumann, I. D., Jurek, B., & Pandamooz, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168464 · Cited by 13 · see citing works

Oxytocin receptor ligands: a survey of the patent literature

Gimpl, G. (2008) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.18.11.1239 · Cited by 13 · see citing works

Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1 a receptors

Jorgensen, W. T., Gulliver, D. W., Werry, E. L., Reekie, T. A., Connor, M. A., & Kassiou, M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.11.050 · Cited by 13 · see citing works

Binding of agonist WAY-267,464 and antagonist WAY-methylated to oxytocin receptor probed by all-atom molecular dynamics simulations

Uba, A. İ., Radicella, C., Readmond, C., Scorese, N., Liao, S., Liu, H., & Wu, C. F. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117643 · Cited by 12 · see citing works

Oxytocin stimulates lipolysis, prostaglandin E2 synthesis, and leptin secretion in 3T3-L1 adipocytes

Assinder, S. J., & Boumelhem, B. B. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111381 · Cited by 12 · see citing works

Enantiospecific Synthesis and Biological Investigations of a Nuphar Alkaloid: Proposed Structure of a Castoreum Component

Seki, H., & Georg, G. I. (2014) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201402232 · Cited by 11 · see citing works

Photoswitchable Probes of Oxytocin and Vasopressin

Wirth, U., Raabe, K., Kalaba, P., Keimpema, E., Muttenthaler, M., & König, B. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01415 · Cited by 10 · see citing works

Species differences in the effect of oxytocin on maternal behavior: A model incorporating the potential for allomaternal contributions

Taylor, J. H., & Grieb, Z. A. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.100996 · Cited by 10 · see citing works

Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humansPreprint

Martins, D. A., Mazibuko, N., Zelaya, F. O., Vasilakopoulou, S., Loveridge, J., Oates, A., Maltezos, S., Mehta, M. A., Wastling, S. J., Howard, M. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/563056 · Cited by 9 · see citing works

Role of oxytocin and vasopressin in alcohol use disorder

Scarboro, S. M., López, M. F., & Becker, H. C. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.08.006 · Cited by 7 · see citing works

Oxytocin neurons in the paraventricular and supraoptic hypothalamic nuclei bidirectionally modulate food intake

Rea, J. J., Liu, C. M., Hayes, A., Ohan, R., Schwartz, G. M., Bashaw, A. G., Klug, M. E., Décarie-Spain, L., Park, Y., Kao, A. E., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102220 · Cited by 9 · see citing works

dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells

Centrone, M., D’Agostino, M., Ranieri, M., Mola, M. G., Faviana, P., Lippolis, P. V., Silvestris, D. A., Venneri, M. G., Mise, A. D., Valenti, G., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.919438 · Cited by 8 · see citing works

Differential Role of Neurohypophysial Hormones in Hypotension and Nitric Oxide Production During Endotoxaemia

Stabile, A. M., Moreto, V., Batalhão, M. E., Rocha, M. J. A., Antunes‐Rodrigues, J., & Cárnio, E. C. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12391 · Cited by 8 · see citing works

Critical role of V1a vasopressin receptor in murine parturition†

Tsuchiya, H., Fujimura, S., Fujiwara, Y., & Koshimizu, T. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz220 · Cited by 7 · see citing works

Conformationally rigid derivatives of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin-1a receptors

Jorgensen, W. T., Gulliver, D. W., Katte, T. A., Werry, E. L., Reekie, T. A., Connor, M. A., & Kassiou, M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.059 · Cited by 6 · see citing works

Intradermal Injection of Oxytocin Aggravates Chloroquine-Induced Itch Responses via Activating the Vasopressin-1a Receptor/Nitric Oxide Pathway in Mice

Li, R., Sun, H., Zheng, H., Zong, Z., Li, S., Meng, T., Li, J., Liu, Y., Wang, C., & Li, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01380 · Cited by 6 · see citing works

Vasopressin V1a and V1b receptor modulators: a patent review (2012 – 2014)

Ślusarz, M. J. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1026257 · Cited by 6 · see citing works

Oxytocin differentially effects 3β-hydroxysteroid dehydrogenase and 5α-reductase activities in prostate cancer cell lines

Assinder, S. J., Davies, K., Surija, J., & Liu-Fu, F. (2015) · Peptides · doi:10.1016/j.peptides.2015.07.015 · Cited by 5 · see citing works

Neuropeptide Receptors

Jr.Devi, G. (2013) · Colloquium Series on Neuropeptides · doi:10.4199/c00082ed1v01y201304npe004 · Cited by 5 · see citing works

Oxytocin accelerates tight junction formation and impairs cellular migration in 3D spheroids: evidence from Gapmer-induced exon skipping

Jurek, B., Denk, L., Schäfer, N., Salehi, M. S., Pandamooz, S., & Haerteis, S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1000538 · Cited by 4 · see citing works

Vasopressin-induced intracellular Ca2+ concentration responses in non-neuronal cells of the rat dorsal root ganglion

Moriya, T., Kayano, T., Kitamura, N., Hosaka, Y. Z., ASANO, A., Forostyak, O., Verkhratsky, A., Viéro, C., Dayanithi, G., Toescu, E. C., et al. (2012) · Brain Research · doi:10.1016/j.brainres.2012.08.028 · Cited by 4 · see citing works

Stimulating oxytocin receptors in the basolateral amygdala enhances stimulus processing: Differential and consistent effects for stimuli paired with fear versus sucrose in extinction and reversal learning

Fam, J. P., Holmes, N. M., & Westbrook, R. F. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106917 · Cited by 4 · see citing works

Family Resemblances? Ligand Binding and Activation of Family A and B G-Protein-Coupled Receptors

Poyner, D. R., & Wheatley, M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350707 · Cited by 4 · see citing works

Fluorescent Peptide Tracers for Simultaneous Oxytocin Receptor Activation and Visualization

Perisic, M., Kalaba, P., Gormal, R. S., Zupančič, M., Wolf, A., Juračić, M., Kremsmayr, T., Meunier, F. A., Langer, T., Gruber, C. W., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202515180 · Cited by 3 · see citing works

Comparison of the pharmacologic profiles of arginine vasopressin and oxytocin analogs at marmoset, titi monkey, macaque, and human oxytocin receptors

Pierce, M. L., French, J. A., & Murray, T. F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109832 · Cited by 3 · see citing works

Vasopressin V1a receptor and oxytocin receptor regulate murine sperm motility differently

Tsuchiya, H., Fujinoki, M., Azuma, M., & Koshimizu, T. (2023) · Life Science Alliance · doi:10.26508/lsa.202201488 · Cited by 3 · see citing works

Vasopressin Type 2 Receptor Agonists and Antagonists

Ranieri, M., Mise, A. D., Tamma, G., & Valenti, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00148-1 · Cited by 3 · see citing works

Oxytocin increases itch sensitivity of mice in late pregnancy and its peripheral receptor mechanism of itch-promoting effect

Yang, G., Wang, X., Chen, L., Wu, Z.-Y., Xi, E.-P., & Li, H. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110749 · Cited by 2 · see citing works

Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an “easy guide” to receptor pharmacology

CHINI, B., MANNING, M., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00438-x · Cited by 65 · see citing works

Molecular Pharmacology of Human Vasopressin Receptors

Thibonnier, M., Conarty, D. M., Preston, J. A., Wilkins, P. L., Berti‐Mattera, L. N., & Mattera, R. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_34 · Cited by 145 · see citing works

Design, Synthesis and Some uses of Receptor-Specific Agonists and Antagonists of Vasopressin and Oxytocin

Manning, M., & Sawyer, W. H. (1993) · Journal of Receptor Research · doi:10.3109/10799899309073655 · Cited by 90 · see citing works

Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors

Busnelli, M., Bulgheroni, E., Manning, M., Kleinau, G., & Chini, B. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.202994 · Cited by 102 · see citing works

G-Protein-Coupled Receptors: from Structural Insights to Functional Mechanisms 197 Insights into the molecular evolution of oxytocin

(2016)